222 related articles for article (PubMed ID: 4369217)
1. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
Anderson T; Schein PS; McMenamin MG; Cooney DA
J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
[TBL] [Abstract][Full Text] [Related]
2. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
Okamoto H; Yamamoto H
Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
[TBL] [Abstract][Full Text] [Related]
3. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
Yale JF; Grose M; Videtic GM; Marliss EB
Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
[TBL] [Abstract][Full Text] [Related]
5. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
Hassan N; Janjua MZ
J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
[TBL] [Abstract][Full Text] [Related]
6. Diabetogenic action of streptozotocin: relationship of dose to metabolic response.
Junod A; Lambert AE; Stauffacher W; Renold AE
J Clin Invest; 1969 Nov; 48(11):2129-39. PubMed ID: 4241908
[TBL] [Abstract][Full Text] [Related]
7. Tilapia islet grafts are highly alloxan-resistant.
Xu BY; Morrison CM; Yang H; Wright JR
Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125
[TBL] [Abstract][Full Text] [Related]
8. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic uptake of [2-(14)C]alloxan.
Malaisse WJ; Doherty M; Ladrière L; Malaisse-Lagae F
Int J Mol Med; 2001 Mar; 7(3):311-5. PubMed ID: 11179513
[TBL] [Abstract][Full Text] [Related]
10. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
Sandler S; Swenne I
Diabetes Res; 1985 Sep; 2(5):255-8. PubMed ID: 2933209
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Doi K
Nihon Naibunpi Gakkai Zasshi; 1975 Mar; 51(3):129-47. PubMed ID: 169168
[TBL] [Abstract][Full Text] [Related]
12. DNA synthesis in pancreatic islet and acinar cells in rats with streptozotocin-induced diabetes.
Hamming NA; Reynolds WA
Horm Metab Res; 1977 Mar; 9(2):114-6. PubMed ID: 140841
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic effect through islet cell protection in streptozotocin diabetes: a preliminary assessment of two thiazolidin-4-ones in Swiss albino mice.
Kishore A; Nampurath GK; Mathew SP; Zachariah RT; Potu BK; Rao MS; Valiathan M; Chamallamudi MR
Chem Biol Interact; 2009 Feb; 177(3):242-6. PubMed ID: 19038238
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
Schein PS; Cooney DA; McMenamin MG; Anderson T
Biochem Pharmacol; 1973 Oct; 22(20):2625-31. PubMed ID: 4357891
[No Abstract] [Full Text] [Related]
15. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
16. Multiple low-dose and single high-dose treatments with streptozotocin do not generate nitric oxide.
Papaccio G; Pisanti FA; Latronico MV; Ammendola E; Galdieri M
J Cell Biochem; 2000 Feb; 77(1):82-91. PubMed ID: 10679819
[TBL] [Abstract][Full Text] [Related]
17. NAD synthesis from nicotinic acid by the hepatocytes prepared from diabetic rats.
Shin M; Maeda S; Hashimoto Y; Sano K; Umezawa C
Int J Vitam Nutr Res; 1995; 65(2):143-6. PubMed ID: 7591535
[TBL] [Abstract][Full Text] [Related]
18. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
19. [Streptozotocin].
Rudas B
Arzneimittelforschung; 1972 May; 22(5):830-61. PubMed ID: 4340253
[No Abstract] [Full Text] [Related]
20. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide.
Gunnarsson R; Berne C; Hellerström C
Biochem J; 1974 Jun; 140(3):487-94. PubMed ID: 4374939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
